EP1333857 - IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 10.01.2014 Database last updated on 14.11.2024 | Most recent event Tooltip | 10.01.2014 | Application deemed to be withdrawn | published on 12.02.2014 [2014/07] | Applicant(s) | For all designated states Apovia, Inc. Suite A, 11125 Flintkote San Diego, CA 92121 / US | [N/P] |
Former [2003/33] | For all designated states Apovia, INC. Suite A, 11125 Flintkote San Diego, CA 92121 / US | Inventor(s) | 01 /
BIRKETT, Ashley, J. 2409 Old Ranch Road Escondido, CA 92027 / US | [2003/33] | Representative(s) | Fisher, Adrian John, et al Carpmaels & Ransford LLP One Southampton Row London WC1B 5HA / GB | [N/P] |
Former [2003/33] | Fisher, Adrian John, et al CARPMAELS & RANSFORD 43 Bloomsbury Square London WC1A 2RA / GB | Application number, filing date | 01964615.7 | 16.08.2001 | [2003/33] | WO2001US41759 | Priority number, date | US20000225843P | 16.08.2000 Original published format: US 225843 P | US20000226867P | 22.08.2000 Original published format: US 226867 P | US20010930915 | 15.08.2001 Original published format: US 930915 | [2003/33] | Filing language | EN | Procedural language | EN | Publication | Type: | A2 Application without search report | No.: | WO0214478 | Date: | 21.02.2002 | Language: | EN | [2002/08] | Type: | A2 Application without search report | No.: | EP1333857 | Date: | 13.08.2003 | Language: | EN | The application published by WIPO in one of the EPO official languages on 21.02.2002 takes the place of the publication of the European patent application. | [2003/33] | Search report(s) | International search report - published on: | US | 05.06.2003 | (Supplementary) European search report - dispatched on: | EP | 12.01.2006 | Classification | IPC: | A61K39/29, A61K39/00, A61K39/385, A61K39/02, C12N15/36, C07K14/02, C07H21/04 | [2003/33] | CPC: |
C07K14/005 (EP,US);
C07K14/02 (KR);
A61P31/00 (EP);
A61P31/04 (EP);
A61P31/12 (EP);
A61P31/16 (EP);
A61P31/18 (EP);
A61P33/00 (EP);
C07K14/445 (EP,US);
C07K14/4711 (EP,US);
C07K14/50 (EP,US);
C12N9/0077 (EP,US);
A61K2039/5258 (EP,US);
A61K2039/54 (EP,US);
A61K2039/555 (EP,US);
A61K2039/57 (EP,US);
C07K2319/00 (EP,US);
C12N2730/10122 (EP,US);
C12N2740/13022 (EP,US);
C12N2740/16222 (EP,US);
C12N2770/32122 (EP,US);
Y02A50/30 (EP,US)
(-)
| Designated contracting states | AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE, TR [2003/33] | Extension states | AL | 24.02.2003 | LT | 24.02.2003 | LV | 24.02.2003 | MK | 24.02.2003 | RO | 24.02.2003 | SI | 24.02.2003 | Title | German: | IMMUNOGENE, HBC-CHIMÄRENPARTIKEL MIT ERHÖHTER STABILITÄT | [2003/33] | English: | IMMUNOGENIC HBc CHIMER PARTICLES HAVING ENHANCED STABILITY | [2003/33] | French: | PARTICULES CHIMERIQUES IMMUNOGENES DE HBC PRESENTANT UNE STABILITE AMELIOREE | [2003/33] | Entry into regional phase | 20.02.2003 | National basic fee paid | 20.02.2003 | Search fee paid | 20.02.2003 | Designation fee(s) paid | 20.02.2003 | Examination fee paid | Examination procedure | 25.02.2002 | Request for preliminary examination filed International Preliminary Examining Authority: US | 20.02.2003 | Amendment by applicant (claims and/or description) | 20.02.2003 | Examination requested [2003/33] | 07.09.2006 | Despatch of a communication from the examining division (Time limit: M04) | 09.01.2007 | Reply to a communication from the examining division | 02.06.2008 | Despatch of a communication from the examining division (Time limit: M06) | 12.12.2008 | Reply to a communication from the examining division | 11.11.2009 | Despatch of a communication from the examining division (Time limit: M06) | 20.05.2010 | Reply to a communication from the examining division | 06.07.2011 | Despatch of a communication from the examining division (Time limit: M06) | 22.12.2011 | Reply to a communication from the examining division | 09.04.2013 | Despatch of a communication from the examining division (Time limit: M04) | 20.08.2013 | Application deemed to be withdrawn, date of legal effect [2014/07] | 24.09.2013 | Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2014/07] | Divisional application(s) | The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is 07.09.2006 | Fees paid | Renewal fee | 20.02.2003 | Renewal fee patent year 03 | 12.08.2004 | Renewal fee patent year 04 | 12.08.2005 | Renewal fee patent year 05 | 14.08.2006 | Renewal fee patent year 06 | 14.08.2007 | Renewal fee patent year 07 | 28.08.2008 | Renewal fee patent year 08 | 12.08.2009 | Renewal fee patent year 09 | 17.08.2010 | Renewal fee patent year 10 | 11.08.2011 | Renewal fee patent year 11 | 10.08.2012 | Renewal fee patent year 12 | Penalty fee | Additional fee for renewal fee | 31.08.2013 | 13   M06   Not yet paid |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [X] - ZLOTNICK A ET AL, "Localization of the C terminus of the assembly domain of hepatitis B virus capsid protein: Implications for morphogenesis and organization of encapsidated RNA", PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF USA, NATIONAL ACADEMY OF SCIENCE, WASHINGTON, DC, US, (199709), vol. 94, ISSN 0027-8424, pages 9556 - 9561, XP002982400 [X] 1-51 * the whole document * DOI: http://dx.doi.org/10.1073/pnas.94.18.9556 | [A] - PUMPENS P ET AL, "Hepatitis B virus core particles as epitope carriers", INTERVIROLOGY, (1995), vol. 38, ISSN 0300-5526, pages 63 - 74, XP002903139 [A] 1-51 * the whole document * | International search | [Y]WO9940934 (IMMUNE COMPLEX CORP [US]); | [Y]US5990085 (IRELAND JAMES J [US], et al); | [A] - PUMPENS P. ET AL., "Hepatitis B core particles as a universal display model: a structure-function basis for development", FEBS LETTERS, (199901), vol. 442, no. 1, pages 1 - 6, XP002937462 DOI: http://dx.doi.org/10.1016/S0014-5793(98)01599-3 | [Y] - SEIFER M. ET AL., "Stability governs the apparent expression of "particulate" hepatitis e antigen by mutant hepatitis B virus core particles", VIROLOGY, (199309), vol. 196, no. 1, pages 70 - 78, XP002961918 DOI: http://dx.doi.org/10.1006/viro.1993.1455 | [Y] - ZHOU ET AL., "Cys residues of the hepatitis B virus capsid protein are not essential for the assembly of viral core particles but can influence their stability", JOURNAL OF VIROLOGY, (199209), vol. 66, no. 9, pages 5393 - 5398, XP002961917 |